138 |
Westermann |
Tumor Suppressor Functions of the Rb-Skp2 Pathway Are Disabled in High-Risk but Functional in Low-Risk Neuroblastomas |
139 |
Sala |
ApoJ/Clusterin Is a Suppressor of Neuroblastoma Metastasis |
140 |
Hansford |
Tumor Initiating Cells in Childhood Neuroblastoma |
141 |
Meier |
Characterization and Functional Analysis of Cancer Stem Cells in Human Neuroblastoma |
142 |
Meier |
Increased Aggressive Behaviour in Neuroblastoma Is Conferred by Activation of the CXCL12/CXCR4 Axis |
143 |
Pistoia |
Human Neuroblastoma Cells Express Functional CXCR5 and CCR3 |
144 |
Ding |
Bmi-1 as a Key Regulator of Self-Renewal and Differentiation of Neuroblastoma Stem Cells |
145 |
Walton |
"What's up" in Human Neuroblastoma Malignant Stem Cells |
146 |
Spengler |
Prognostic Significance of Tumor Stem Cell Frequency: A Retrospective Analysis of 60 Patients with Neuroblastoma |
147 |
Mora |
Characterization of Multipotential Precursor Cells from Neuroblastic Tumors |
148 |
Takenobu |
Cancer Stem Cells of Neuroblastoma: Identification of Nbla30102 and p63 as the Candidate Markers |
149 |
Kuroda |
An Evidence of Multiclonal Oncogenesis in Neuroblastoma |
150 |
Jagannathan |
Identification of Genes Implicated in Neuroblastoma Angiogenesis Using an Automated Text Mining Process |
151 |
Corrias |
Angiogenesis in a Human Neuroblastoma Xenograft Model: Mechanisms and Inhibition by Tumor-Derived Interferon-γ |
152 |
Chlenski |
RNAi Inhibition of SPARC Expression in Neuroblastoma Leads to Stimulation of Angiogenesis and Enhanced Drug Resistance |
153 |
Peddinti |
Blood Vessels in Clinically Aggressive Neuroblastomas Are Highly Disorganized and Structurally Abnormal |
154 |
Tan |
Nerve Growth Factor Activation of TrkA Induces Vascular Endothelial Growth Factor Expression Via Hypoxia-Inducible Factor-1α in Neuroblastoma Cells |
155 |
Yoon |
Role of Matrix Metalloproteinase-9 in Neuroblastoma Angiogenesis |
156 |
Pastorino |
Study of Human Neuroblastoma Progression Using Proteome Analysis |
157 |
Winter |
Post-Transcriptional Modulation of Neural Cell Adhesion Molecule (NCAM) Is Associated with Neuroblastoma Metastatic Potential |
158 |
McKee |
PTHrP, a Mediator of Bone Metastasis, Is a Target of TrkB but Not TrkA in Neuroblastoma |
159 |
Fukaya |
Tumor Necrosis Factor Alpha (TNFα) Stimulates Interleukin-6 (IL-6) Expression by Bone Marrow Mesenchymal Stem Cells: A Mechanism for Bone Metastasis of Neuroblastoma |
160 |
Ara |
Bone Marrow Stromal-Derived Interleukin-6 Stimulates Proliferation and Survival of Neuroblastoma Cells in the Bone Marrow Microenvironment |
161 |
Zhang |
The Dynamic Changes of Bone Marrow Invaded by Neuroblastoma |
162 |
Torkin |
The Role of Proneurotrophins and Sortilin in Migration and Metastasis of Neuroblastoma |
163 |
Raffaghello |
CXCL12 Does Not Attract CXCR4+ Human Metastatic Neuroblastoma Cells: Clinical Implications |
164 |
Zhang |
Neuroblastoma Growth and Metastasis Regulated by Chemokine Receptors |
165 |
Wesley |
Role of Dipeptidyl Peptidase IV in Regulating the Growth and Differentiation of Neuroblastoma Cells |
166 |
Raffaghello |
Chemokines and Lymphocyte Recruitment to Opsoclonus-Myoclonus Syndrome Associated Neuroblastic Tumors |
167 |
Shang |
The Role of CD4+ Regulatory T Cells in Neuroblastoma |
168 |
Lin |
Quantifying Overexpression of p53 and MDM2 Proteins by Flow Cytometry Identifies Multi-Drug Resistant Neuroblastoma Cells, Including Those Retaining p53 Function |
169 |
Grigoryan |
Flow Cytometry Analysis of Single Strand DNA Damage in Neuroblastoma Cell Lines Using the F7-26 Monoclonal Antibody |
170 |
Wagner |
MGMT Expression Is Ubiquitous in Primary Neuroblastoma Tumors |
171 |
Ambros |
Induction of Cell Senescence in MYCN Amplified Neuroblastoma Cell Lines by Hydroxyurea |
172 |
George |
Does MYCN Amplification Manifested as Homogenously Staining Regions Predict a Worse Outcome in Neuroblastoma? A Children's Oncology Group Study |
173 |
Schneiderman |
Hyperdiploidy Is Associated with Favorable Outcome in Patients with MYCN-Amplified INSS Stage 1, 2, and 4S Neuroblastoma |
174 |
Gordin |
Clinical Significance of Trk Family Gene Expression in Human Neuroblastomas |
175 |
Higashi |
The Neuronatin Gene Expression as a Favorable Prognostic Factor in Neuroblastoma |
176 |
Sartelet |
Expression of Erythropoietin and Its Receptor in Neuroblastomas |
177 |
Kishida |
Involvement of Midkine, a Heparin-Binding Growth Factor, in Neuroblastoma |
178 |
Raffaghello |
The P2X7 Receptor Sustains the Growth of Human Neuroblastoma Cells through a Substance P Dependent Mechanism |
179 |
Castro |
Establishing Neuroblastoma Cell Lines in a Central Laboratory: The Initial Children's Oncology Group Experience |
180 |
Sugimoto |
MYCN-Amplified Neuroblastoma Cell Line Established from a Patient with Long-Term-Survival and Serum Levels of MYCN DNA during the Clinical Course |
181 |
Wang |
In Vitro Culture of Bone Marrow Metastatic Neuroblastoma Cells |
182 |
Rovigatti |
Genetic Model of Neuroblastoma Progression Based upon Viral Persistent Infection |
183 |
Jackson |
High Resolution MIBG Imaging in Neuroblastoma Murine Xenografts |
184 |
Castaldo |
Direct Demonstration of the Role for the Noradrenaline Transporter (NAT) in Uptake of Meta-Iodobenzylguanidine (MIBG) in Neuroblastoma Cell Lines |
